tiprankstipranks
Trending News
More News >
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
US Market

Teva (TEVA) Ratios

Compare
47 Followers

Teva Ratios

IL:TEVA's free cash flow for Q3 2025 was $0.51. For the 2025 fiscal year, IL:TEVA's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.11 0.98 1.02 1.05 1.14
Quick Ratio
0.82 0.75 0.69 0.72 0.79
Cash Ratio
0.19 0.26 0.26 0.24 0.20
Solvency Ratio
0.05 -0.02 0.02 -0.03 0.05
Operating Cash Flow Ratio
0.09 0.10 0.11 0.14 0.07
Short-Term Operating Cash Flow Coverage
44.42 0.70 0.82 0.75 0.56
Net Current Asset Value
$ -19.87B$ -21.05B$ -22.87B$ -23.26B$ -23.85B
Leverage Ratios
Debt-to-Assets Ratio
0.43 0.46 0.46 0.49 0.49
Debt-to-Equity Ratio
2.36 3.36 2.68 2.73 2.28
Debt-to-Capital Ratio
0.70 0.77 0.73 0.73 0.70
Long-Term Debt-to-Capital Ratio
0.70 0.75 0.71 0.71 0.68
Financial Leverage Ratio
5.50 7.32 5.79 5.57 4.64
Debt Service Coverage Ratio
2.83 0.04 0.58 -0.09 1.69
Interest Coverage Ratio
2.09 -0.30 0.42 -2.17 1.62
Debt to Market Cap
0.46 0.70 1.68 2.12 2.41
Interest Debt Per Share
15.66 16.87 18.95 20.29 22.25
Net Debt to EBITDA
5.34 19.02 10.86 -20.28 4.83
Profitability Margins
Gross Profit Margin
50.09%48.74%48.25%46.72%47.83%
EBIT Margin
10.57%-1.70%2.56%-14.96%9.76%
EBITDA Margin
16.61%4.70%9.83%-6.20%27.77%
Operating Profit Margin
10.89%-1.83%2.73%-14.06%10.81%
Pretax Profit Margin
5.35%-7.76%-3.93%-20.54%4.14%
Net Profit Margin
4.24%-9.91%-3.53%-15.77%2.63%
Continuous Operations Profit Margin
3.94%-11.84%-3.88%-16.74%2.87%
Net Income Per EBT
79.29%127.65%89.87%76.77%63.37%
EBT Per EBIT
49.15%423.76%-143.65%146.02%38.34%
Return on Assets (ROA)
1.79%-4.17%-1.29%-5.35%0.87%
Return on Equity (ROE)
11.08%-30.50%-7.45%-29.80%4.06%
Return on Capital Employed (ROCE)
6.44%-1.14%1.39%-6.45%4.68%
Return on Invested Capital (ROIC)
4.73%-1.07%1.30%-4.78%3.05%
Return on Tangible Assets
3.56%-8.29%-2.67%-11.70%2.07%
Earnings Yield
1.94%-6.49%-4.73%-23.47%4.36%
Efficiency Ratios
Receivables Turnover
4.40 5.41 4.65 4.04 3.51
Payables Turnover
3.56 3.85 3.15 4.21 4.91
Inventory Turnover
2.52 2.82 2.04 2.07 2.17
Fixed Asset Turnover
3.25 3.34 2.58 2.42 2.45
Asset Turnover
0.42 0.42 0.36 0.34 0.33
Working Capital Turnover Ratio
16.74 -5.51K 38.65 14.03 22.90
Cash Conversion Cycle
125.09 102.09 141.66 179.71 198.05
Days of Sales Outstanding
82.90 67.49 78.50 90.39 104.11
Days of Inventory Outstanding
144.86 129.41 178.98 175.94 168.22
Days of Payables Outstanding
102.66 94.81 115.82 86.61 74.29
Operating Cycle
227.75 196.90 257.48 266.32 272.34
Cash Flow Ratios
Operating Cash Flow Per Share
0.93 1.10 1.22 1.43 0.72
Free Cash Flow Per Share
0.50 0.66 0.75 0.94 0.21
CapEx Per Share
0.43 0.44 0.47 0.49 0.51
Free Cash Flow to Operating Cash Flow
0.54 0.60 0.62 0.66 0.30
Dividend Paid and CapEx Coverage Ratio
2.18 2.50 2.60 2.90 1.42
Capital Expenditure Coverage Ratio
2.18 2.50 2.60 2.90 1.42
Operating Cash Flow Coverage Ratio
0.06 0.07 0.07 0.07 0.03
Operating Cash Flow to Sales Ratio
0.06 0.08 0.09 0.11 0.05
Free Cash Flow Yield
1.57%2.97%7.12%10.39%2.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
51.44 -15.40 -21.16 -4.26 22.92
Price-to-Sales (P/S) Ratio
2.18 1.53 0.75 0.67 0.60
Price-to-Book (P/B) Ratio
5.05 4.70 1.58 1.27 0.93
Price-to-Free Cash Flow (P/FCF) Ratio
63.38 33.70 14.05 9.62 40.50
Price-to-Operating Cash Flow Ratio
34.36 20.24 8.65 6.31 11.98
Price-to-Earnings Growth (PEG) Ratio
0.09 -0.08 0.28 <0.01 -0.21
Price-to-Fair Value
5.05 4.70 1.58 1.27 0.93
Enterprise Value Multiple
18.49 51.51 18.46 -31.12 7.00
Enterprise Value
51.59B 40.02B 28.75B 28.79B 30.85B
EV to EBITDA
18.51 51.51 18.46 -31.12 7.00
EV to Sales
3.08 2.42 1.81 1.93 1.94
EV to Free Cash Flow
89.25 53.43 34.15 27.63 130.73
EV to Operating Cash Flow
48.39 32.09 21.02 18.11 38.66
Tangible Book Value Per Share
-11.01 -12.24 -12.91 -13.70 -14.76
Shareholders’ Equity Per Share
6.32 4.75 6.71 7.11 9.33
Tax and Other Ratios
Effective Tax Rate
0.27 -0.53 0.01 0.21 0.32
Revenue Per Share
14.63 14.63 14.17 13.45 14.41
Net Income Per Share
0.62 -1.45 -0.50 -2.12 0.38
Tax Burden
0.79 1.28 0.90 0.77 0.63
Interest Burden
0.51 4.55 -1.54 1.37 0.42
Research & Development to Revenue
0.06 0.06 0.07 0.06 0.06
SG&A to Revenue
0.07 0.07 0.07 0.08 0.07
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.61 -0.64 -2.45 -0.66 1.75
Currency in USD